1-Up On Wall Street: Sony Is the New Netflix, Syfy Is Diseased, and Starz Seeks TV Ratings Treasure

Can Sony deliver games the way Netflix delivers videos? Will Syfy's medical thriller Helix heal recent ratings woes? Will enough people watch the pirates of Black Sails or the travails of a time-displaced nurse in Outlander to make Starz stock pay off for investors? Ellen Bowman, Nathan Alderman, and Tim Beyers have these stories and the dish on the design (or lack thereof) for X-Men: Days of Future Past in this week's episode of 1-Up on Wall Street!

Level up your earning potential!
Want to figure out how to profit on business analysis like this? The key is to learn how to turn business insights into portfolio gold by taking your first steps as an investor. In our brand-new special report, "Your Essential Guide to Start Investing Today," The Motley Fool's personal finance experts show you what you need to get started, and even gives you access to some stocks to buy first. Click here to get your copy today -- it's absolutely free.

The article 1-Up On Wall Street: Sony Is the New Netflix, Syfy Is Diseased, and Starz Seeks TV Ratings Treasure originally appeared on Fool.com.

Neither Ellen Bowman nor Nathan Alderman owns shares in any of the stocks mentioned. Tim Beyers owns shares of Netflix. The Motley Fool recommends AMC Networks, Netflix, Nvidia, and Take-Two Interactive. The Motley Fool owns shares of Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.